Your browser doesn't support javascript.
loading
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study.
Xiong, Liwen; Li, Rong; Sun, Jiayuan; Lou, Yuqing; Zhang, Weiyan; Bai, Hao; Wang, Huiming; Shen, Jie; Jing, Bo; Shi, Chunlei; Zhong, Hua; Gu, Aiqin; Jiang, Liyan; Shi, Jianxing; Fang, Wentao; Zhao, Heng; Zhang, Jie; Wang, Junyuan; Ye, Junyi; Han, Baohui.
Affiliation
  • Xiong L; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Li R; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Sun J; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Lou Y; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Zhang W; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Bai H; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Wang H; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Shen J; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Jing B; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Shi C; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Zhong H; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Gu A; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Jiang L; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Shi J; Department of Thoracic Sugery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Fang W; Department of Thoracic Sugery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Zhao H; Department of Thoracic Sugery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Zhang J; Department of Pathology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Wang J; Best Biotech Ltd, Dalian, Liaoning, China.
  • Ye J; Burning Rock Biotech, Guangzhou, China.
  • Han B; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China xkyyhanbh@outlook.com.
Oncologist ; 24(2): 157-e64, 2019 02.
Article in En | MEDLINE | ID: mdl-30158288
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Erlotinib Hydrochloride / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Erlotinib Hydrochloride / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: China